Furthermore, Δ9-tetrahydrocannabinol (THC), an active cannabinoid in Cannabis sativa L. plants, has also garnered much attention for its inhibition of DEGS1 in gliomas (Table 1) [149,150]. This evidence concerns the gene DEGS1 and central nervous system cancer.